Logo image of 5Q5.DE

SNOWFLAKE INC (5Q5.DE) Stock Fundamental Analysis

FRA:5Q5 - Deutsche Boerse Ag - US8334451098 - Common Stock - Currency: EUR

181.34  -3.58 (-1.94%)

Fundamental Rating

4

Overall 5Q5 gets a fundamental rating of 4 out of 10. We evaluated 5Q5 against 74 industry peers in the IT Services industry. While 5Q5 seems to be doing ok healthwise, there are quite some concerns on its profitability. 5Q5 shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

5Q5 had positive earnings in the past year.
5Q5 had a positive operating cash flow in the past year.
In the past 5 years 5Q5 always reported negative net income.
5Q5 had a positive operating cash flow in 4 of the past 5 years.
5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCF5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -17.15%, 5Q5 is doing worse than 83.78% of the companies in the same industry.
5Q5 has a worse Return On Equity (-58.09%) than 82.43% of its industry peers.
Industry RankSector Rank
ROA -17.15%
ROE -58.09%
ROIC N/A
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
5Q5.DE Yearly ROA, ROE, ROIC5Q5.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

5Q5 has a Gross Margin of 66.58%. This is comparable to the rest of the industry: 5Q5 outperforms 56.76% of its industry peers.
In the last couple of years the Gross Margin of 5Q5 has grown nicely.
The Profit Margin and Operating Margin are not available for 5Q5 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.5%
5Q5.DE Yearly Profit, Operating, Gross Margins5Q5.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

5

2. Health

2.1 Basic Checks

5Q5 does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 5Q5 has about the same amount of shares outstanding.
5Q5 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 5Q5 is higher compared to a year ago.
5Q5.DE Yearly Shares Outstanding5Q5.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
5Q5.DE Yearly Total Debt VS Total Assets5Q5.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

5Q5 has an Altman-Z score of 6.28. This indicates that 5Q5 is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.28, 5Q5 belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
The Debt to FCF ratio of 5Q5 is 3.09, which is a good value as it means it would take 5Q5, 3.09 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 5Q5 (3.09) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.94 indicates that 5Q5 is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.94, 5Q5 is not doing good in the industry: 67.57% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 3.09
Altman-Z 6.28
ROIC/WACCN/A
WACC9.6%
5Q5.DE Yearly LT Debt VS Equity VS FCF5Q5.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.58 indicates that 5Q5 should not have too much problems paying its short term obligations.
5Q5 has a better Current ratio (1.58) than 72.97% of its industry peers.
A Quick Ratio of 1.58 indicates that 5Q5 should not have too much problems paying its short term obligations.
The Quick ratio of 5Q5 (1.58) is better than 81.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
5Q5.DE Yearly Current Assets VS Current Liabilites5Q5.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

8

3. Growth

3.1 Past

The earnings per share for 5Q5 have decreased by -4.17% in the last year.
The Earnings Per Share has been growing by 334.45% on average over the past years. This is a very strong growth
The Revenue has grown by 27.50% in the past year. This is a very strong growth!
5Q5 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 68.79% yearly.
EPS 1Y (TTM)-4.17%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%71.43%
Revenue 1Y (TTM)27.5%
Revenue growth 3Y43.81%
Revenue growth 5Y68.79%
Sales Q2Q%25.75%

3.2 Future

Based on estimates for the next years, 5Q5 will show a very strong growth in Earnings Per Share. The EPS will grow by 40.26% on average per year.
The Revenue is expected to grow by 22.97% on average over the next years. This is a very strong growth
EPS Next Y35.75%
EPS Next 2Y38.91%
EPS Next 3Y40.92%
EPS Next 5Y40.26%
Revenue Next Year25.85%
Revenue Next 2Y24.32%
Revenue Next 3Y24.04%
Revenue Next 5Y22.97%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
5Q5.DE Yearly Revenue VS Estimates5Q5.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
5Q5.DE Yearly EPS VS Estimates5Q5.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 229.54, the valuation of 5Q5 can be described as expensive.
5Q5's Price/Earnings ratio is a bit more expensive when compared to the industry. 5Q5 is more expensive than 70.27% of the companies in the same industry.
5Q5 is valuated expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
5Q5 is valuated quite expensively with a Price/Forward Earnings ratio of 134.19.
67.57% of the companies in the same industry are cheaper than 5Q5, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.76. 5Q5 is valued rather expensively when compared to this.
Industry RankSector Rank
PE 229.54
Fwd PE 134.19
5Q5.DE Price Earnings VS Forward Price Earnings5Q5.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

70.27% of the companies in the same industry are cheaper than 5Q5, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 96.27
EV/EBITDA N/A
5Q5.DE Per share data5Q5.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
5Q5's earnings are expected to grow with 40.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)6.42
PEG (5Y)N/A
EPS Next 2Y38.91%
EPS Next 3Y40.92%

0

5. Dividend

5.1 Amount

5Q5 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SNOWFLAKE INC

FRA:5Q5 (7/11/2025, 7:00:00 PM)

181.34

-3.58 (-1.94%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-21 2025-05-21/amc
Earnings (Next)08-19 2025-08-19/amc
Inst Owners67.07%
Inst Owner ChangeN/A
Ins Owners2.72%
Ins Owner ChangeN/A
Market Cap60.51B
Analysts80.71
Price Target202.07 (11.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)39.55%
Min EPS beat(2)10.37%
Max EPS beat(2)68.73%
EPS beat(4)4
Avg EPS beat(4)29.8%
Min EPS beat(4)10.37%
Max EPS beat(4)68.73%
EPS beat(8)7
Avg EPS beat(8)43.89%
EPS beat(12)10
Avg EPS beat(12)37.76%
EPS beat(16)14
Avg EPS beat(16)123.76%
Revenue beat(2)2
Avg Revenue beat(2)1.33%
Min Revenue beat(2)1.2%
Max Revenue beat(2)1.47%
Revenue beat(4)4
Avg Revenue beat(4)1.42%
Min Revenue beat(4)0.06%
Max Revenue beat(4)2.97%
Revenue beat(8)7
Avg Revenue beat(8)1.23%
Revenue beat(12)11
Avg Revenue beat(12)1.36%
Revenue beat(16)15
Avg Revenue beat(16)1.81%
PT rev (1m)9.11%
PT rev (3m)0.63%
EPS NQ rev (1m)0.39%
EPS NQ rev (3m)4.2%
EPS NY rev (1m)-4.54%
EPS NY rev (3m)-2.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.74%
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)1.12%
Valuation
Industry RankSector Rank
PE 229.54
Fwd PE 134.19
P/S 18.45
P/FCF 96.27
P/OCF 85.08
P/B 29.42
P/tB 64.55
EV/EBITDA N/A
EPS(TTM)0.79
EY0.44%
EPS(NY)1.35
Fwd EY0.75%
FCF(TTM)1.88
FCFY1.04%
OCF(TTM)2.13
OCFY1.18%
SpS9.83
BVpS6.16
TBVpS2.81
PEG (NY)6.42
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.15%
ROE -58.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.58%
FCFM 19.17%
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.5%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 3.09
Debt/EBITDA N/A
Cap/Depr 50.65%
Cap/Sales 2.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 6.28
F-Score4
WACC9.6%
ROIC/WACCN/A
Cap/Depr(3y)67.2%
Cap/Depr(5y)189.29%
Cap/Sales(3y)2.66%
Cap/Sales(5y)4.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.17%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%71.43%
EPS Next Y35.75%
EPS Next 2Y38.91%
EPS Next 3Y40.92%
EPS Next 5Y40.26%
Revenue 1Y (TTM)27.5%
Revenue growth 3Y43.81%
Revenue growth 5Y68.79%
Sales Q2Q%25.75%
Revenue Next Year25.85%
Revenue Next 2Y24.32%
Revenue Next 3Y24.04%
Revenue Next 5Y22.97%
EBIT growth 1Y-22.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.26%
EBIT Next 3Y82.3%
EBIT Next 5Y79.48%
FCF growth 1Y21.33%
FCF growth 3Y149.53%
FCF growth 5YN/A
OCF growth 1Y26.07%
OCF growth 3Y105.74%
OCF growth 5YN/A